Innate Immunity and Leishmania Vaccination Strategies
- 31 January 2011
- journal article
- review article
- Published by Elsevier BV in Dermatologic Clinics
- Vol. 29 (1), 89-102
- https://doi.org/10.1016/j.det.2010.08.014
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Histopathological analysis of initial cellular response in TLR‐2 deficient mice experimentally infected by Leishmania (L.) amazonensisInternational Journal of Experimental Pathology, 2010
- Toll‐like receptors – sentries in the B‐cell responseImmunology, 2009
- The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasisCellular Microbiology, 2009
- Leishmania amazonensispromastigotes induce and are killed by neutrophil extracellular trapsProceedings of the National Academy of Sciences of the United States of America, 2009
- Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster modelProceedings of the National Academy of Sciences of the United States of America, 2008
- L-arginine metabolism and its impact on host immunity against Leishmania infectionImmunologic Research, 2007
- Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasisThe Journal of Experimental Medicine, 2007
- CpG DNA inhibits CD4+CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cellsImmunology Letters, 2007
- MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll‐like receptor 2 signalingEuropean Journal of Immunology, 2003
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001